ロード中...
Adiponectin Paradox as a Therapeutic Target in Alzheimer’s Disease
Despite the apparent neurotoxicity of amyloid-β (Aβ), recent clinical trials of Aβ immunotherapy have not shown any clinical benefit in Alzheimer’s disease (AD). Given this, clarification of the next generation therapeutic strategy in AD is warranted. Hypothetically, adiponectin might be involved in...
保存先:
| 出版年: | J Alzheimers Dis |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
IOS Press
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7504987/ https://ncbi.nlm.nih.gov/pubmed/32623396 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/JAD-200416 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|